REV: Responsibly and reliably powering industry
With a focus on the creation of innovative technology and forward-thinking practical solutions, REV offers flexible, durable, reliable
Kramer Mazda: The largest Mazda dealership in Western Canada
The largest Mazda dealership in Calgary and Western Canada, for over 40 years Kramer Mazda has been developing
German-Canadian Care Home: An innovative new vision for elder care
Providing compassionate care to seniors in Vancouver for over 50 years, the German-Canadian Care Home is part of
Hinton Scaffold Solutions: Utilizing innovate technologies to create safer worksites
With many years of experience in the heavy industrial scaffold industry, Ontario-based Hinton Scaffold Solutions provides highly innovative
Alberta Veterinary Laboratories / Solvet: Supporting Canada’s food
Founded in 2009, Western Canadian family-owned pharmaceutical manufacturer Alberta Veterinary Laboratories manufactures and provides efficacious and cost-effective animal
Sodexo Canada: The global leader who believes the difference a day makes
Founded in Marseille in 1966, and now operating in 53 countries, Sodexo provides facilities services that drive positive
Barclay Restorations DKI: The longest running insurance restoration company in Greater Vancouver
Locally owned-and operated and serving Metro Vancouver and the Fraser Valley, Barclay Restorations DKI is a full-service restoration
CDW Canada: Helping small businesses use IT security to prepare, defend, and respond
Established in 2003, CDW Canada is a leading provider of technology solutions for business, government, education, and healthcare,
Taiwan: key to win-win approach for Canadian Industry
Taiwan’s innovation leadership and significant economic potential in Asia is an opportunity for Canada to stay competitive on
Taking charitable giving to the next level
Empowering employees to support the causes that matter most to them is the best way to maximize charitable
Lots of money seeking company acquisitions – The case of private equity
At this time, there is more money in the system than anyone can imagine. It is estimated that
There’s optimism amid instability in the Canadian construction landscape
The last year has been among the most expensive on record for many Canadians. Families and those on
Washed up elites need to stop lecturing the people
The ramblings of ex-Prime Ministers, Presidents and CEOs is a feature of all political life, history and cultures.
The political timing of Finland’s admission into NATO
It has been a few weeks since the world watched the proverbial ink of approval dry on Finland’s
How to manage the stress of making the right business decisions
It can be stressful when you have to make important decisions regarding your business. We all want to
Reclaiming Canada’s key service export: Tourism
Tourism is an increasingly dynamic sector of the global economy; pre-2019 tourism was a $1.4 trillion industry generating
Valeant Announces Sale of iNova Pharmaceuticals for $930 Million
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (“Valeant”) has announced it has entered into an agreement to sell its iNova Pharmaceuticals (“iNova”) business to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group for $930 million in cash.
“The sale of iNova is part of the company’s ongoing efforts to both simplify our operating model and strengthen our balance sheet,” said Joseph C. Papa, chairman and chief executive officer, Valeant. “We will continue to evaluate opportunities that will enable us to deliver on our commitments and unlock value for shareholders.”
iNova, which markets a diversified portfolio of prescription and over-the-counter products in several areas, such as weight management, pain management, cardiology and cough and cold, operates in more than 15 countries around the world. iNova holds leading market positions in Australia and South Africa and also has an established platform in Asia.
Valeant will maintain a strong footprint in these countries primarily through its Bausch + Lomb franchise.
Valeant will use proceeds from the sale to permanently repay term loan debt under its Senior Secured Credit Facility. The transaction is expected to close in the second half of 2017, subject to customary closing conditions, including receipt of applicable regulatory approvals.
In this transaction, Goldman, Sachs & Co. served as financial advisor to Valeant, and Baker McKenzie acted as legal advisor to Valeant.
- Read the current edition
- Recent posts
